Hood River Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,256,580
| Closed | -$50.5M | – | 157 |
|
|
2025
Q1 | $50.5M | Buy |
1,256,580
+267,332
| +27% | +$10.7M | 0.86% | 50 |
|
|
2024
Q4 | $46.5M | Sell |
989,248
-1,548
| -0.2% | -$72.8K | 0.69% | 59 |
|
|
2024
Q3 | $52.3M | Buy |
990,796
+253,159
| +34% | +$13.4M | 0.84% | 47 |
|
|
2024
Q2 | $40M | Buy |
737,637
+40,990
| +6% | +$2.22M | 0.83% | 48 |
|
|
2024
Q1 | $48.8M | Buy |
696,647
+135,666
| +24% | +$9.51M | 1.09% | 30 |
|
|
2023
Q4 | $46.8M | Buy |
560,981
+58,455
| +12% | +$4.88M | 1.29% | 29 |
|
|
2023
Q3 | $14.8M | Sell |
502,526
-1
| -0% | -$29 | 0.48% | 73 |
|
|
2023
Q2 | $16.4M | Buy |
502,527
+16,255
| +3% | +$530K | 0.49% | 71 |
|
|
2023
Q1 | $17.1M | Buy |
486,272
+10,799
| +2% | +$380K | 0.55% | 62 |
|
|
2022
Q4 | $21.8M | Sell |
475,473
-394,479
| -45% | -$18.1M | 0.79% | 51 |
|
|
2022
Q3 | $42.1M | Buy |
869,952
+18,047
| +2% | +$874K | 1.61% | 19 |
|
|
2022
Q2 | $33.5M | Buy |
851,905
+46,331
| +6% | +$1.82M | 1.33% | 25 |
|
|
2022
Q1 | $29.7M | Buy |
805,574
+185,910
| +30% | +$6.84M | 0.99% | 38 |
|
|
2021
Q4 | $28.2M | Sell |
619,664
-3,992
| -0.6% | -$182K | 0.85% | 45 |
|
|
2021
Q3 | $22.3M | Buy |
+623,656
| New | +$22.3M | 0.69% | 53 |
|